Prior Case of Resistance on Dolutegravir plus Lamivudine Dual Therapy

Babafemi O. Taiwo; Miguel E. Quiñones-Mateu; Kimberly Smith; Lu Zheng; Roy Gulick; Amesika N. Nyaku; Paul E. Sax; Belinda Ha; Johnstone Kumwenda; Maxine Olefsky; Catherine Godfrey; Carole Wallis

doi:10.1089/aid.2019.0253

Prior Case of Resistance on Dolutegravir plus Lamivudine Dual Therapy

Babafemi O. Taiwo^*, Miguel E. Quiñones-Mateu, Kimberly Smith, Lu Zheng, Roy Gulick, Amesika N. Nyaku, Paul E. Sax, Belinda Ha, Johnstone Kumwenda, Maxine Olefsky, Catherine Godfrey, Carole Wallis

^*Corresponding author for this work

Medicine, Infectious Diseases Division

Research output: Contribution to journal › Letter › peer-review

2 Scopus citations

Original language	English (US)
Pages (from-to)	254-255
Number of pages	2
Journal	AIDS research and human retroviruses
Volume	36
Issue number	4
DOIs	https://doi.org/10.1089/aid.2019.0253
State	Published - Apr 2020

ASJC Scopus subject areas

Infectious Diseases
Virology
Immunology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1089/aid.2019.0253

Cite this

@article{6f9c59ff23aa4ad3abcf225a0f84abfb,

title = "Prior Case of Resistance on Dolutegravir plus Lamivudine Dual Therapy",

author = "Taiwo, {Babafemi O.} and Qui{\~n}ones-Mateu, {Miguel E.} and Kimberly Smith and Lu Zheng and Roy Gulick and Nyaku, {Amesika N.} and Sax, {Paul E.} and Belinda Ha and Johnstone Kumwenda and Maxine Olefsky and Catherine Godfrey and Carole Wallis",

note = "Funding Information: Research reported in this publication was supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under award numbers UM1 AI068634, UM1 AI068636, and UM1 AI106701. ViiV Healthcare provided the study medications.",

year = "2020",

month = apr,

doi = "10.1089/aid.2019.0253",

language = "English (US)",

volume = "36",

pages = "254--255",

journal = "AIDS research and human retroviruses",

issn = "0889-2229",

publisher = "Mary Ann Liebert Inc.",

number = "4",

}

TY - JOUR

T1 - Prior Case of Resistance on Dolutegravir plus Lamivudine Dual Therapy

AU - Taiwo, Babafemi O.

AU - Quiñones-Mateu, Miguel E.

AU - Smith, Kimberly

AU - Zheng, Lu

AU - Gulick, Roy

AU - Nyaku, Amesika N.

AU - Sax, Paul E.

AU - Ha, Belinda

AU - Kumwenda, Johnstone

AU - Olefsky, Maxine

AU - Godfrey, Catherine

AU - Wallis, Carole

N1 - Funding Information: Research reported in this publication was supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under award numbers UM1 AI068634, UM1 AI068636, and UM1 AI106701. ViiV Healthcare provided the study medications.

PY - 2020/4

Y1 - 2020/4

UR - http://www.scopus.com/inward/record.url?scp=85083310090&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85083310090&partnerID=8YFLogxK

U2 - 10.1089/aid.2019.0253

DO - 10.1089/aid.2019.0253

M3 - Letter

C2 - 31914799

AN - SCOPUS:85083310090

SN - 0889-2229

VL - 36

SP - 254

EP - 255

JO - AIDS research and human retroviruses

JF - AIDS research and human retroviruses

IS - 4

ER -

Prior Case of Resistance on Dolutegravir plus Lamivudine Dual Therapy

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this